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Objective. Prior to the 2013 US Preventive Services Task Force (USPSTF) guidelines for lung cancer screening,
the American Cancer Society released interim guidance recommending physicians discuss lung cancer screening
with high risk patients. We included a question on patient–provider discussions about lung cancer screening on a
statewide population-based survey to establish baseline prevalence for surveillance and to identify subpopulation
disparities.
Methods.Weanalyzed the 2012/2013Kansas Adult Tobacco Survey to assess patient–provider discussions about
lung cancer screening.Weighted prevalence estimates and adjusted odds ratioswere calculated to examine charac-
teristics associated with discussing screening.
Results. The prevalence of patient–provider discussions about lung cancer screening among current and former
smokers aged55 to 74yearswas 31.0% (95%CI 27.0–35.0). The adjustedprevalence odds of having thesediscussions
was higher amongmales, adults aged 65 to 74 years, adults livingwith a disability, aswell as thosewho sawahealth
professional in the past year and had their smoking status assessed or were advised to quit.
Conclusions. The current study is unique as it is the ﬁrst to assess patient–provider discussions about lung cancer
screening using a statewide survey. These results may inform strategies to increase patient–provider discussions
about lung cancer screening among high risk Kansans.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Lung cancer is the leading cause of cancer death in Kansas (U.S.
Cancer Statistics Working Group, 2013). Early detection is key for im-
proving survival. Currently, 5-year relative survival is 54% when diag-
nosed in localized stage, but nearly half of lung cancer cases are
diagnosed in distant stage, where 5-year relative survival is only 4%
(Surveillance, Epidemiology, and End Results Program, 2014). Prior to
2013, there were no lung cancer screening recommendations from the
US Preventive Services Task Force (USPSTF) (Moyer, 2013). Despite
the absence of these guidelines prior to 2013, low dose computed to-
mography (LDCT) and chest x-rays have been used for lung cancer
screening. In a 2006/2007 national survey of primary care physicians,
55% reported they had ordered chest x-rays, and 22% had ordered
LDCT for lung cancer screening (Klabunde et al., 2012). Further, in the
2010 National Health Interview Survey, 2.5% of Americans 40 years
and older without a prior diagnosis of lung cancer reported chest x-lth and Environment, Bureau of
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. This is an open access article underray for lung cancer screening, while 1.3% reported LDCT for lung cancer
screening (Doria-Rose et al., 2012).
In 2011, the National Lung Screening Trial (NLST) found that screen-
ingwith LDCT can reduce lung cancer mortality among high risk groups
by 20% when compared to screening with chest x-ray (National Lung
Screening Trial Research Team et al., 2011). Following these results,
the American Cancer Society (ACS) released interim guidance on lung
cancer screening, which recommended that adults who meet NLST
eligibility criteria should discuss lung cancer screening using LDCT
with their health care provider (HCP) and make a shared decision as
to whether or not to be screened. These guidelines also stressed that
screening is not an alternative to smoking cessation (Fontham, 2011).
Based on these recommendations, the Kansas Comprehensive Cancer
Prevention and Control Program included a question on the 2012/
2013 Kansas Adult Tobacco Survey (ATS) to assess the prevalence of
current and former smokers who have discussedwith their HCPwhether
or not to be screened for lung cancer.
We anticipate that results from the NLST and the growing number
of organizations recommending the use of LDCT for lung cancer screening
will increase screening rates among high risk populations. To our knowl-
edge, this study is the ﬁrst to estimate the prevalence of patient–providerthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Prevalence odds of patient–provider discussions about lung cancer screening among
current and former smokers aged 55 to 74 years, Kansas ATS 2012/2013 (n = 733).
Crude OR 95% CI Adjusted OR 95% CI
Gender
Female 1.00 – 1.00 –
Male 1.53 (1.05–2.23) 1.57a (1.07–2.52)
Age
55–64 1.00 – 1.00 –
65–74 1.68 (1.15–2.46) 1.57a (1.12–2.52)
Disability status
Not living with a disability 1.00 – 1.00 –
Living with a disability 1.53 (1.04–2.24) 1.70a (1.15–2.92)
Insurance coverage
Has insurance 1.00 –
Does not have insurance 0.92 (0.49–1.73)
Income
b$25,000 1.00 –
$25,000–$49,999 1.03 (0.62–1.71)
≥$50,000 0.77 (0.48–1.25)
Saw health professional in past year
Yes 1.00 –
No 1.41 (0.79–2.51)
Saw a health care professional in past year and had tobacco use status assessed
No 1.00 – 1.00 –
Yes 2.44 (1.51–3.93) 2.50† (1.54–4.07)
Saw a health care professional in past year and were advised to stop using tobacco
No 1.00 – 1.00 –
Yes 1.79 (1.04–3.08) 1.78† (1.02–3.09)
a Final model includes gender, age and disability status.
† Odds ratios adjusted for gender, age, and disability status.
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subpopulations in Kansas.
Methods
The 2012/2013 Kansas ATS is a point‐in‐time, random-digit-dial-
survey of non‐institutionalized adults 18 years and older living in a
private residence in Kansas with landline and/or cell phone service.
An overlapping frame sampling methodology was implemented and
the sample was stratiﬁed by county population density subgroups.
Data were weighted using iterative proportional ﬁtting, or “raking,”
across severalmargins including: age, gender, race/ethnicity, education,
home ownership, and region. Additional information on the 2012/2013
Kansas ATS weighting methodology has been previously published
(Christensen et al., 2014).
Current smokers and former smokers (who had their last cigarette in
the past 15 years) aged 55 to 74 years with no history of cancer were
asked the question “Have you discussed with your health care provider
whether or not to be screened for lung cancer?” Other relevant data
collected include socio-demographic characteristics, visits with a HCP,
provider assessment of tobacco use and provider advice to quit. Respon-
dents were considered to be living with a disability if they indicated
they were limited in activities because of physical, mental, or emotional
problems or if they had a health problem that required the use of special
equipment. Provider assessment of tobacco use was determined by the
question “In the past 12months, did any doctor, dentist, nurse, or other
health professional ask if you smoke cigarettes or use any other tobacco
products?” Provider advice to quit was determined by the question
“In the past 12 months, did any doctor, dentist, nurse, or other health
professional advise you to quit smoking cigarettes or using any other
tobacco products?”
Weighted prevalence estimates and 95% conﬁdence limits were
computed taking into account complex survey methodology. Logistic
regression models were developed to examine characteristics associated
with discussing screening while adjusting for potential confounding
variables. Models were assessed for confounding, interaction, and collin-
earity in a forward selection process. All statistical analyseswere conduct-
ed using SAS 9.3 software.
Results
The Kansas ATSwas completed by 9656 Kansas adults, 733 of whom
were identiﬁed as current or former smokers aged 55 to 74 years with
no history of cancer. In 2012 to 2013, 31.0% (95% CI: 27.0%–35.0%) of
current and former smokers aged 55 to 74 years in Kansas had discussed
whether or not to be screened for lung cancer with a HCP. The preva-
lence odds of discussing screening was higher among males than
females (adjusted OR = 1.57, 95% CI 1.07–2.52), higher among
adults aged 65 to 74 years than adults aged 55 to 64 years (adjusted
OR = 1.57, 95% CI 1.12–2.52), and higher among adults living with a
disability than those not living with a disability (adjusted OR =
1.70, 95% CI 1.15–2.92) [Table 1].
We further explored data among respondents who had seen a HCP
within the past year while adjusting for age, gender and disability
status. We found that the prevalence odds of discussing lung cancer
screening was higher among those who had their smoking status
assessed by their HCP than those who did not (adjusted OR = 2.50,
95% CI 1.54–4.07) and higher among those who were advised to
quit by their HCP than those who were not advised to quit (adjusted
OR = 1.78, 95% CI 1.02–3.09).
Discussion
In 2012/2013, nearly one-third of current and former smokers aged
55 to 74 years in Kansas had ever discussed lung cancer screening with
their HCP. Differences in the prevalence odds of patient–providerdiscussions by age and gender could be due to differences in the per-
ceived risk of lung cancer linked to historical smoking disparities in
this age cohort by gender (U.S. Department of Health and Human
Services, 2014). Differences by disability status could be related to dis-
parities in health care access affecting individuals with disability
(Kansas Behavioral Risk Factor Surveillance System, 2014).
Our ﬁndings that a health care professional's assessment of smoking
status and providing advice to quit is associated with discussing screen-
ingmay provide opportunities for intervention. These differences could
be due to physician knowledge and attitudes regarding lung cancer risk
and screening. Screening is not a replacement for smoking cessation in-
tervention, but both should be discussed between high risk smokers
and their HCP. The role of provider knowledge and attitudes may be
better understood through further investigation and should be consid-
ered when developing interventions to increase lung cancer screening
discussions.
This study is not without limitations. The survey did not ascertain
pack-year smoking history; not all current and former smokers in this
study will meet screening guidelines. Although pack-year smoking
history was unmeasured, we anticipate a large proportion of our study
population meeting the pack-year requirement. When asked about
the age at which they had their ﬁrst cigarette, 92.5% of our study popu-
lation reported initiating smoking before the age of 25. Nonetheless,
some in our sample may bemisclassiﬁed as high risk despite a smoking
history of less than 30 pack-years.
In addition, the question used to assess patient–provider discussions
of lung cancer screening does not differentiate between screening
modalities and thus does not necessarily measure discussing screening
according to guidelines recommending LDCT. Despite this limitation,
we expect that this indicator provides adequate information to identify
subpopulation disparities and trends over time, and provide useful
information for developing targeted interventions. We were unable
to stratify data by race and ethnicity due to the small sample size of non-
579A.R. Rogers et al. / Preventive Medicine Reports 2 (2015) 577–579white respondents. In addition, self-report of having a discussion about
lung cancer screening may be affected by recall bias.
The current study is unique in that, to our knowledge, it is the ﬁrst to
assess patient–provider discussions about lung cancer screening at the
population level using a statewide health survey. Results from this
study can be used to inform strategies to increase patient–provider dis-
cussions about lung cancer screening among high risk individuals, as
well as strategies to increase provider awareness around this issue.
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